1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Over-the-counter (OTC) Testing Kits
        1.2.3 Prescription-based Testing Kits
    1.3 Market by Application
        1.3.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Bacterial Infections
        1.3.3 Fungal Infection
        1.3.4 Virus Infection
        1.3.5 Cardiovascular Infection
        1.3.6 Gastrointestinal Infection
        1.3.7 Sexually Transmitted Disease (STD) Infection
        1.3.8 Central Nervous System Infection
        1.3.9 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Infectious Disease Point of Care Diagnostics Market Perspective (2017-2028)
    2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Region
        2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Infectious Disease Point of Care Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Infectious Disease Point of Care Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Infectious Disease Point of Care Diagnostics Market Dynamics
        2.3.1 Infectious Disease Point of Care Diagnostics Industry Trends
        2.3.2 Infectious Disease Point of Care Diagnostics Market Drivers
        2.3.3 Infectious Disease Point of Care Diagnostics Market Challenges
        2.3.4 Infectious Disease Point of Care Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue
        3.1.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
    3.4 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio
        3.4.1 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Point of Care Diagnostics Revenue in 2021
    3.5 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served
    3.6 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
    3.7 Date of Enter into Infectious Disease Point of Care Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Point of Care Diagnostics Breakdown Data by Type
    4.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2023-2028)
5 Infectious Disease Point of Care Diagnostics Breakdown Data by Application
    5.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Infectious Disease Point of Care Diagnostics Market Size (2017-2028)
    6.2 North America Infectious Disease Point of Care Diagnostics Market Size by Type
        6.2.1 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
        6.2.2 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2028)
        6.2.3 North America Infectious Disease Point of Care Diagnostics Market Share by Type (2017-2028)
    6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Application
        6.3.1 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
        6.3.2 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2028)
        6.3.3 North America Infectious Disease Point of Care Diagnostics Market Share by Application (2017-2028)
    6.4 North America Infectious Disease Point of Care Diagnostics Market Size by Country
        6.4.1 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
        6.4.2 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2017-2028)
    7.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Type
        7.2.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
        7.2.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2028)
        7.2.3 Europe Infectious Disease Point of Care Diagnostics Market Share by Type (2017-2028)
    7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Application
        7.3.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
        7.3.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2028)
        7.3.3 Europe Infectious Disease Point of Care Diagnostics Market Share by Application (2017-2028)
    7.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Country
        7.4.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
        7.4.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Infectious Disease Point of Care Diagnostics Market Size (2017-2028)
    9.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Type
        9.2.1 Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
        9.2.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2028)
        9.2.3 Latin America Infectious Disease Point of Care Diagnostics Market Share by Type (2017-2028)
    9.3 Latin America Infectious Disease Point of Care Diagnostics Market Size by Application
        9.3.1 Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
        9.3.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2028)
        9.3.3 Latin America Infectious Disease Point of Care Diagnostics Market Share by Application (2017-2028)
    9.4 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country
        9.4.1 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
        9.4.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Infectious Disease Point of Care Diagnostics Introduction
        11.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.1.5 Abbott Recent Developments
    11.2 Siemens
        11.2.1 Siemens Company Details
        11.2.2 Siemens Business Overview
        11.2.3 Siemens Infectious Disease Point of Care Diagnostics Introduction
        11.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.2.5 Siemens Recent Developments
    11.3 GE Healthcare
        11.3.1 GE Healthcare Company Details
        11.3.2 GE Healthcare Business Overview
        11.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Introduction
        11.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.3.5 GE Healthcare Recent Developments
    11.4 Accriva
        11.4.1 Accriva Company Details
        11.4.2 Accriva Business Overview
        11.4.3 Accriva Infectious Disease Point of Care Diagnostics Introduction
        11.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.4.5 Accriva Recent Developments
    11.5 Terumo
        11.5.1 Terumo Company Details
        11.5.2 Terumo Business Overview
        11.5.3 Terumo Infectious Disease Point of Care Diagnostics Introduction
        11.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.5.5 Terumo Recent Developments
    11.6 BioMerieux
        11.6.1 BioMerieux Company Details
        11.6.2 BioMerieux Business Overview
        11.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Introduction
        11.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.6.5 BioMerieux Recent Developments
    11.7 Diasorin
        11.7.1 Diasorin Company Details
        11.7.2 Diasorin Business Overview
        11.7.3 Diasorin Infectious Disease Point of Care Diagnostics Introduction
        11.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.7.5 Diasorin Recent Developments
    11.8 Roche
        11.8.1 Roche Company Details
        11.8.2 Roche Business Overview
        11.8.3 Roche Infectious Disease Point of Care Diagnostics Introduction
        11.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.8.5 Roche Recent Developments
    11.9 Danaher Corporation
        11.9.1 Danaher Corporation Company Details
        11.9.2 Danaher Corporation Business Overview
        11.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Introduction
        11.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.9.5 Danaher Corporation Recent Developments
    11.10 BD
        11.10.1 BD Company Details
        11.10.2 BD Business Overview
        11.10.3 BD Infectious Disease Point of Care Diagnostics Introduction
        11.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.10.5 BD Recent Developments
    11.11 Bio-Rad Laboratories
        11.11.1 Bio-Rad Laboratories Company Details
        11.11.2 Bio-Rad Laboratories Business Overview
        11.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Introduction
        11.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.11.5 Bio-Rad Laboratories Recent Developments
    11.12 Cavidi
        11.12.1 Cavidi Company Details
        11.12.2 Cavidi Business Overview
        11.12.3 Cavidi Infectious Disease Point of Care Diagnostics Introduction
        11.12.4 Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.12.5 Cavidi Recent Developments
    11.13 Cepheid
        11.13.1 Cepheid Company Details
        11.13.2 Cepheid Business Overview
        11.13.3 Cepheid Infectious Disease Point of Care Diagnostics Introduction
        11.13.4 Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.13.5 Cepheid Recent Developments
    11.14 Diaxonhit
        11.14.1 Diaxonhit Company Details
        11.14.2 Diaxonhit Business Overview
        11.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Introduction
        11.14.4 Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.14.5 Diaxonhit Recent Developments
    11.15 Eiken Chemical
        11.15.1 Eiken Chemical Company Details
        11.15.2 Eiken Chemical Business Overview
        11.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Introduction
        11.15.4 Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.15.5 Eiken Chemical Recent Developments
    11.16 EMD Millipore
        11.16.1 EMD Millipore Company Details
        11.16.2 EMD Millipore Business Overview
        11.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Introduction
        11.16.4 EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.16.5 EMD Millipore Recent Developments
    11.17 Epitope Diagnostic
        11.17.1 Epitope Diagnostic Company Details
        11.17.2 Epitope Diagnostic Business Overview
        11.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Introduction
        11.17.4 Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.17.5 Epitope Diagnostic Recent Developments
    11.18 Euroimmun
        11.18.1 Euroimmun Company Details
        11.18.2 Euroimmun Business Overview
        11.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Introduction
        11.18.4 Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.18.5 Euroimmun Recent Developments
    11.19 Gold Standard Diagnostics
        11.19.1 Gold Standard Diagnostics Company Details
        11.19.2 Gold Standard Diagnostics Business Overview
        11.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Introduction
        11.19.4 Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.19.5 Gold Standard Diagnostics Recent Developments
    11.20 Hologic
        11.20.1 Hologic Company Details
        11.20.2 Hologic Business Overview
        11.20.3 Hologic Infectious Disease Point of Care Diagnostics Introduction
        11.20.4 Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.20.5 Hologic Recent Developments
    11.21 Immunetics
        11.21.1 Immunetics Company Details
        11.21.2 Immunetics Business Overview
        11.21.3 Immunetics Infectious Disease Point of Care Diagnostics Introduction
        11.21.4 Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.21.5 Immunetics Recent Developments
    11.22 InBios International
        11.22.1 InBios International Company Details
        11.22.2 InBios International Business Overview
        11.22.3 InBios International Infectious Disease Point of Care Diagnostics Introduction
        11.22.4 InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.22.5 InBios International Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Over-the-counter (OTC) Testing Kits
    Table 3. Key Players of Prescription-based Testing Kits
    Table 4. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Infectious Disease Point of Care Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Infectious Disease Point of Care Diagnostics Market Share by Region (2017-2022)
    Table 8. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Infectious Disease Point of Care Diagnostics Market Share by Region (2023-2028)
    Table 10. Infectious Disease Point of Care Diagnostics Market Trends
    Table 11. Infectious Disease Point of Care Diagnostics Market Drivers
    Table 12. Infectious Disease Point of Care Diagnostics Market Challenges
    Table 13. Infectious Disease Point of Care Diagnostics Market Restraints
    Table 14. Global Infectious Disease Point of Care Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Infectious Disease Point of Care Diagnostics Revenue Share by Players (2017-2022)
    Table 16. Global Top Infectious Disease Point of Care Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2021)
    Table 17. Ranking of Global Top Infectious Disease Point of Care Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Infectious Disease Point of Care Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
    Table 21. Date of Enter into Infectious Disease Point of Care Diagnostics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2017-2022)
    Table 25. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2023-2028)
    Table 27. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Infectious Disease Point of Care Diagnostics Revenue Share by Application (2017-2022)
    Table 29. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Infectious Disease Point of Care Diagnostics Revenue Share by Application (2023-2028)
    Table 31. North America Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Abbott Company Details
    Table 62. Abbott Business Overview
    Table 63. Abbott Infectious Disease Point of Care Diagnostics Product
    Table 64. Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 65. Abbott Recent Developments
    Table 66. Siemens Company Details
    Table 67. Siemens Business Overview
    Table 68. Siemens Infectious Disease Point of Care Diagnostics Product
    Table 69. Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 70. Siemens Recent Developments
    Table 71. GE Healthcare Company Details
    Table 72. GE Healthcare Business Overview
    Table 73. GE Healthcare Infectious Disease Point of Care Diagnostics Product
    Table 74. GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 75. GE Healthcare Recent Developments
    Table 76. Accriva Company Details
    Table 77. Accriva Business Overview
    Table 78. Accriva Infectious Disease Point of Care Diagnostics Product
    Table 79. Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 80. Accriva Recent Developments
    Table 81. Terumo Company Details
    Table 82. Terumo Business Overview
    Table 83. Terumo Infectious Disease Point of Care Diagnostics Product
    Table 84. Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 85. Terumo Recent Developments
    Table 86. BioMerieux Company Details
    Table 87. BioMerieux Business Overview
    Table 88. BioMerieux Infectious Disease Point of Care Diagnostics Product
    Table 89. BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 90. BioMerieux Recent Developments
    Table 91. Diasorin Company Details
    Table 92. Diasorin Business Overview
    Table 93. Diasorin Infectious Disease Point of Care Diagnostics Product
    Table 94. Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 95. Diasorin Recent Developments
    Table 96. Roche Company Details
    Table 97. Roche Business Overview
    Table 98. Roche Infectious Disease Point of Care Diagnostics Product
    Table 99. Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 100. Roche Recent Developments
    Table 101. Danaher Corporation Company Details
    Table 102. Danaher Corporation Business Overview
    Table 103. Danaher Corporation Infectious Disease Point of Care Diagnostics Product
    Table 104. Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 105. Danaher Corporation Recent Developments
    Table 106. BD Company Details
    Table 107. BD Business Overview
    Table 108. BD Infectious Disease Point of Care Diagnostics Product
    Table 109. BD Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 110. BD Recent Developments
    Table 111. Bio-Rad Laboratories Company Details
    Table 112. Bio-Rad Laboratories Business Overview
    Table 113. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product
    Table 114. Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 115. Bio-Rad Laboratories Recent Developments
    Table 116. Cavidi Company Details
    Table 117. Cavidi Business Overview
    Table 118. Cavidi Infectious Disease Point of Care Diagnostics Product
    Table 119. Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 120. Cavidi Recent Developments
    Table 121. Cepheid Company Details
    Table 122. Cepheid Business Overview
    Table 123. Cepheid Infectious Disease Point of Care Diagnostics Product
    Table 124. Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 125. Cepheid Recent Developments
    Table 126. Diaxonhit Company Details
    Table 127. Diaxonhit Business Overview
    Table 128. Diaxonhit Infectious Disease Point of Care Diagnostics Product
    Table 129. Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 130. Diaxonhit Recent Developments
    Table 131. Eiken Chemical Company Details
    Table 132. Eiken Chemical Business Overview
    Table 133. Eiken Chemical Infectious Disease Point of Care Diagnostics Product
    Table 134. Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 135. Eiken Chemical Recent Developments
    Table 136. EMD Millipore Company Details
    Table 137. EMD Millipore Business Overview
    Table 138. EMD Millipore Infectious Disease Point of Care Diagnostics Product
    Table 139. EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 140. EMD Millipore Recent Developments
    Table 141. Epitope Diagnostic Company Details
    Table 142. Epitope Diagnostic Business Overview
    Table 143. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product
    Table 144. Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 145. Epitope Diagnostic Recent Developments
    Table 146. Euroimmun Company Details
    Table 147. Euroimmun Business Overview
    Table 148. Euroimmun Infectious Disease Point of Care Diagnostics Product
    Table 149. Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 150. Euroimmun Recent Developments
    Table 151. Gold Standard Diagnostics Company Details
    Table 152. Gold Standard Diagnostics Business Overview
    Table 153. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product
    Table 154. Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 155. Gold Standard Diagnostics Recent Developments
    Table 156. Hologic Company Details
    Table 157. Hologic Business Overview
    Table 158. Hologic Infectious Disease Point of Care Diagnostics Product
    Table 159. Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 160. Hologic Recent Developments
    Table 161. Immunetics Company Details
    Table 162. Immunetics Business Overview
    Table 163. Immunetics Infectious Disease Point of Care Diagnostics Product
    Table 164. Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 165. Immunetics Recent Developments
    Table 166. InBios International Company Details
    Table 167. InBios International Business Overview
    Table 168. InBios International Infectious Disease Point of Care Diagnostics Product
    Table 169. InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 170. InBios International Recent Developments
    Table 171. Research Programs/Design for This Report
    Table 172. Key Data Information from Secondary Sources
    Table 173. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Infectious Disease Point of Care Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Over-the-counter (OTC) Testing Kits Features
    Figure 3. Prescription-based Testing Kits Features
    Figure 4. Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2021 VS 2028
    Figure 5. Bacterial Infections Case Studies
    Figure 6. Fungal Infection Case Studies
    Figure 7. Virus Infection Case Studies
    Figure 8. Cardiovascular Infection Case Studies
    Figure 9. Gastrointestinal Infection Case Studies
    Figure 10. Sexually Transmitted Disease (STD) Infection Case Studies
    Figure 11. Central Nervous System Infection Case Studies
    Figure 12. Other Case Studies
    Figure 13. Infectious Disease Point of Care Diagnostics Report Years Considered
    Figure 14. Global Infectious Disease Point of Care Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Infectious Disease Point of Care Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Infectious Disease Point of Care Diagnostics Market Share by Region: 2021 VS 2028
    Figure 17. Global Infectious Disease Point of Care Diagnostics Market Share by Players in 2021
    Figure 18. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Infectious Disease Point of Care Diagnostics Revenue in 2021
    Figure 20. North America Infectious Disease Point of Care Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 22. North America Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 23. North America Infectious Disease Point of Care Diagnostics Market Size Share by Country (2017-2028)
    Figure 24. United States Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Infectious Disease Point of Care Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Infectious Disease Point of Care Diagnostics Market Size Share by Country (2017-2028)
    Figure 30. Germany Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Infectious Disease Point of Care Diagnostics Market Size Share by Region (2017-2028)
    Figure 40. China Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 46. Latin America Infectious Disease Point of Care Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Infectious Disease Point of Care Diagnostics Market Size Share by Country (2017-2028)
    Figure 50. Mexico Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Size Share by Country (2017-2028)
    Figure 56. Turkey Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Abbott Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 60. Siemens Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 61. GE Healthcare Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 62. Accriva Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 63. Terumo Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 64. BioMerieux Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 65. Diasorin Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 66. Roche Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 67. Danaher Corporation Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 68. BD Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 69. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 70. Cavidi Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 71. Cepheid Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 72. Diaxonhit Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 73. Eiken Chemical Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 74. EMD Millipore Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 75. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 76. Euroimmun Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 77. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 78. Hologic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 79. Immunetics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 80. InBios International Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed